Jemma Arakelyan: Norman Ng – a remarkable figure in the fight against cancer in Hong Kong
Jemma Arakelyan, Medical Oncologist, CEO at the Institute of Cancer and Crisis, reshared a post on LinkedIn:
“I recently had the privilege of interviewing Norman Ng, a remarkable figure in the fight against cancer in Hong Kong. Back in 2012, he was leading the way at Pfizer as the head of oncology products, introducing Crizotinib, the first-generation ALK inhibitor that changed the lives of lung cancer patients.
Fast forward to today, Norman is facing his own battle with stage 4 ALK-positive lung cancer. Instead of letting this challenge hold him back, he has turned his experience into a mission to help others. Now the Director of Patient Advocacy and Public Affairs for Healthcare Thinkers, he works hard to represent patients and connect with key stakeholders to make sure their voices are heard.
In December 2023, he also became the Convener for the Lung Cancer Patient Concern Group. This group aims to support patients dealing with their diagnoses and raise awareness about lung cancer. Through his leadership, Norman is creating a community where patients can find hope and support.
It was truly inspiring to hear his story and see his dedication to making a difference!”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023